Major histocompatibility complex and inflammatory cell subtype expression in inflammatory myopathies and muscular dystrophies

Neurology India

Volumn 61, Issue 6, 2013, Pages 614-621

  Nagappa, Madhu ^a   Nalini, Atchayaram ^a   Narayanappa, Gayathri ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Dermatomyositis; inflammatory myopathies; MHC I and MHC II; muscular dystrophy; polymyositie

Indexed keywords

ADOLESCENT; ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MYOSITIS; YOUNG ADULT;

EID: 84894166554     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.125264     Document Type: Article

References (19)

1. Mastaglia FL, Garlepp MJ, Phillips BA, Zilko PJ. Inflammatory myopathies: Clinical, diagnostic and therapeutic aspects. Muscle Nerve 2003;27:407-25.
2. Vogel H, Zamecnik J. Diagnostic immunohistology of muscle diseases. J Neuropatho Exp Neurol 2005;64:181-93.
3. Appleyard ST, Dunn MJ, Dubowitz V, Rose ML. Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders. Lancet 1985;2:361-3.
4. Karpati G, Pouliot Y, Carpenter S. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol 1988;23:64-72.
5. McDouall RM, Dunn MJ, Dubowitz V. Expression of class I and class II MHC antigens in neuromuscular diseases. J Neurol Sci 1989;89:213-26.
6. van der Pas J, Hengstman GJ, ter Laak HJ, Borm G F, van Engelen BG. Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J Neurol Neurosurg Psychiat 2004;75:136-9.
7. Jain A, Sharma MC, Sarkar C, Bhatia R, Singh S, Handa R. Major Histocompatibility Complex Class I and II detection as a diagnostic tool idiopathic inflammatory myopathies. Arch Pathol Lab Med 2007;131:1070-6.
8. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003;362:971-82.
9. Confalonieri P, Oliva L, Andreetta F, Lorenzoni R, Dassi P, Mariani E, et al. Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: An immunopathological study. J Neuroimmunol 2003;142:130-6.
10. Sundaram C, Uppin MS, Meena AK. Major Histocompatibility Complex Class I expression can be used as a diagnostic tool to differentiate idiopathic inflammatory myopathies from dystrophies. Neurol India 2008;56:363-7.
11. Englund P, Lindroos E, Nennesmo I, Klareskog L, Lundberg IE. Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies. Am J Pathol 2001;159:1263-73.
12. Matsubara S, Hirai S, Sawa Y. Pulsed intravenous methylprednisolone therapy for inflammatory myopathies: Evaluation of the effect by comparing two consecutive biopsies from the same muscle. J Neuroimmunol 1997;76:75-80.
13. Salaroli R, Baldin E, Papa V, Rinaldi R, Tarantino L, De Giorgi LB, et al. Validity of internal expression of the major histocompatibility complex class I in the diagnosis of inflammatory myopathies. J Clin Pathol 2012;65:14-9.
14. Dalakas MC. Immunopathogenesis of inflammatory myopathies. Ann Neurol 2002;37(suppl):S74-86.
15. Nagaraju K. Update on immunopathogenesis in inflammatory myopathies. Curr Opin Rheumatol 2001;13:461-8.
16. Nagaraju K, Raben N, Loeffler L, Parker T, Rochon PJ, Lee E, et al. Conditional upregulation of MHC class I in skeletal muscle leads to self sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci U S A 2000;97:9209-14.
17. Darin N, Kroksmark AK, Ahlander AC, Moslemi AR, Oldfors A, Tulinius M. Inflammation and response to steroid treatment in limb-girdle muscular dystrophy 2I. Eur J Paediatr Neurol 2007;11:353-7.
18. Kostek CA, Dominov JA, Miller JB. Up-regulation of MHC class I expression accompanies but is not required for spontaneous myopathy in dysferlin-deficient SJL/J mice. Am J Pathol 2002;160:833-9.
19. Nyberg P, Wikman AL, Nennesmo I, Lundberg I. Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and ermatomyositis. J Rheumatol 2000;27:940-8.